기업, 미생물 유전체학

Illumina Statement on Novel Coronavirus

Illumina has enacted precautionary measures focusing on the health and safety of our employees, families, customers and communities.

Illumina Statement on Novel Coronavirus
2020년 3월 17일

With the global spread of SARS-CoV-2, Illumina has enacted precautionary measures focusing on the health and safety of our employees, families, customers and communities. To help protect Illumina employees and business continuity, we have proactively implemented efforts including limiting travel and attendance at meetings and conferences, and allowing employees to work remotely, where possible. We are closely monitoring the situation and will update our action plan to protect employees, keep customers running and support efforts to minimize the spread of the virus. To date, we have not experienced sustained supply chain or other operational delays. We will continue to monitor and update as the situation evolves, balancing the safety of our employees and the needs of our customers. 

 

 

최근 기사

An Illumina milestone powered by our people: 100,000 volunteer hours
An Illumina milestone powered by our people: 100,000 volunteer hours
How genomics can help detect drug-resistant TB earlier
Video: How genomics can help detect drug-resistant TB earlier
In Canada, researching the use of AI to accelerate answers for rare disease
In Canada, researching the use of AI to accelerate answers for rare disease